aye_jamie Photo

Facility
UAB Division of Hematology and Oncology
Children's Title
Physician
Academic Title
Assistant Professor
Credentials
MD
Specialty
Pediatric Hematology Oncology
Gender
Female
Primary Address
1600 7th Ave. S.
Clinic 8
Birmingam, AL 35233
Get Directions
View Map
Clinic Phone Number
(205) 638-9285
County
Jefferson
Secondary Address
1600 7th Avenue South
Birmingham, AL 35233
Get Directions
View Map
Office Phone Number
(205) 638-9285
Fax
(205) 975-1941
Undergraduate
Wake Forest University
Medical School
Mercer University School of Medicine
Internship
University of South Carolina, Palmetto Health
Residency
University of South Carolina, Palmetto Health, Pediatrics
Fellowship
University of Alabama at Birmingham, Children's of Alabama, Pediatric Hematology
Notable Publications and Presentations
1. Stafman, L. L., Williams, A. P., Garner, E. F., Aye, J. M., Stewart, J. E., Yoon, K. J., . . . Beierle, E. A. (2018). Targeting PIM Kinases Affects Maintenance of CD133 Tumor Cell Population in Hepatoblastoma.. Transl Oncol, 12(2), 200-208. doi:10.1016/j.tranon.2018.10.008
2. Williams, A. P., Garner, E. F., Waters, A. M., Stafman, L. L., Aye, J. M., Markert, H., . . . Beierle, E. A. (2018). Investigation of PP2A and Its Endogenous Inhibitors in Neuroblastoma Cell Survival and Tumor Growth.. Transl Oncol, 12(1), 84-95. doi:10.1016/j.tranon.2018.09.011
3. Garner, E. F., Stafman, L. L., Williams, A. P., Aye, J. M., Goolsby, C., Atigadda, V. R., . . . Beierle, E. A. (2018). UAB30, a novel RXR agonist, decreases tumorigenesis and leptomeningeal disease in group 3 medulloblastoma patient-derived xenografts.. J Neurooncol. doi:10.1007/s11060-018-2950-1
4. Stafman, L. L., Mruthyunjayappa, S., Waters, A. M., Garner, E. F., Aye, J. M., Stewart, J. E., . . . Beierle, E. A. (2018). Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma.. Oncotarget, 9(32), 22665-22679. doi:10.18632/oncotarget.25205
5.Garner, E. F., Williams, A. P., Stafman, L. L., Aye, J. M., Mroczek-Musulman, E., Moore, B. P., . . . Beierle, E. A. (2018). FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts.. Sci Rep, 8(1), 6913. doi:10.1038/s41598-018-25263-5
Physician Type
Pediatric Hematologist/Oncologist
Back